Poseida’s Myeloma-specific CAR T-cells Combat Aggressive Cancer in Mice, Study Shows
multiple myeloma, News
Poseida Therapeutics demonstrated that their new CAR T-cell treatment for multiple myeloma — P-BCMA-101 — possessed features that make it stand out in the field of gene-edited cancer cell ... Read more